Analyst Ratings For Immutep (NASDAQ:IMMP)
Today, Maxim Group reiterated its Buy rating on Immutep (NASDAQ:IMMP) with a price target of $5.00.
Some recent analyst ratings include
- 2/15/2018-Maxim Group Reiterated Rating of Buy .
- 4/19/2017-FBR & Co Reiterated Rating of Buy.
- 8/26/2016-Roth Capital Reiterated Rating of Buy.
Recent Trading Activity for Immutep (NASDAQ:IMMP)
Shares of Immutep closed the previous trading session at 1.78 down -0.02 0.89% with 1.784000039100647 shares trading hands.